Radiofrequency Ablation of Leiomyomas.

Obstet Gynecol

Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, Minnesota; the Division of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts; the Department of Obstetrics and Gynecology, Division of Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas; and the Division of Minimally Invasive Gynecologic Surgery, Mayo Clinic, Rochester, Minnesota.

Published: June 2023

Radiofrequency ablation (RFA) of leiomyomas represents a significant advancement in the treatment of this common uterine condition. In the appropriately selected patient, both laparoscopic and transcervical options provide effective treatment for bleeding and bulk symptoms in a uterine-sparing manner. Compared with other minimally invasive leiomyoma treatment options, RFA procedures have comparable or favorable safety profiles, recovery timelines, and reintervention rates. Data on future fertility and pregnancy are limited, although early reports are promising.

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000005196DOI Listing

Publication Analysis

Top Keywords

radiofrequency ablation
8
ablation leiomyomas
4
leiomyomas radiofrequency
4
ablation rfa
4
rfa leiomyomas
4
leiomyomas represents
4
represents advancement
4
advancement treatment
4
treatment common
4
common uterine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!